Dr. Karine Tawagi, MD

  • Chicago, IL
  • Hematologist and oncologist
NPI1447633235PAC ID1355656380
Medicare services, 2024
264
Medicare patients, 2024
67
Part D claims, 2024
690
MIPS score, 2024
93
Hospital affiliations
1
Practice address
1740 West Taylor St Suite 1400, Chicago, IL 60612
Practice phone
Call (312) 996-3900
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

University of Illinois Hospital

Hospital · Chicago, Illinois

See all 3 affiliations

Find Dr. Tawagi's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Karine Tawagi is a hematologist and oncologist in Chicago, Illinois

Dr. Tawagi practices at University of Illinois Hospital in Chicago, Illinois, part of University of Illinois System.

Dr. Tawagi's NPI, 1447633235, was assigned on June 30, 2015. Dr. Tawagi holds Illinois license 036162147.

NPI and contact details
Medicare PAC ID
1355656380
NPI enumeration date
June 30, 2015
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(312) 996-3900
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Female
Estimated age
37
Medical school graduation
2015

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Karine Tawagi practices at University of Illinois Hospital in Chicago, Illinois

Dr. Tawagi's primary practice is University of Illinois Hospital, at 1740 West Taylor St Suite 1400, Chicago, IL 60612 in Cook County. The practice phone is (312) 996-3900.

Source: Dmand AI Affiliation Data

Dr. Karine Tawagi is affiliated with 2 sites of care and 1 medical group

Dr. Tawagi's primary practice is University of Illinois Hospital in Chicago, Illinois, part of University of Illinois System. The medical group on file is University of Illinois Physicians Group (UIPG). Dmand AI also links Dr. Tawagi to 1 more group practice or clinic, named with a free account.

See all 3 affiliations for Dr. Tawagi

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Karine Tawagi's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tawagi practices, 2 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
University of Illinois HospitalAvailable with a free account
+1 more affiliated siteAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Tawagi practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across University of Illinois System and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Karine Tawagi is one of 563 hematologists and oncologists in Illinois

Hematology and oncology is Dr. Tawagi's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Tawagi's licenses on file in 2 states: Illinois and Michigan.

Specialties and state licenses

  • Hematology and oncology, IllinoisPrimaryLicense 036162147 · taxonomy 207RH0003X
  • Internal medicine, MichiganLicense 1447633235 · taxonomy 207R00000X

Hematologists and oncologists near Dr. Tawagi

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Karine Tawagi billed Medicare for 264 services in 2024

CMS data shows 264 Medicare services from Dr. Tawagi across 3 procedure codes in 2024, for 67 Medicare patients. Medicare paid $20,183 for them. Every service was in a facility, such as a hospital, rather than an office.

Medicare services, 2024264
Medicare patients67
Paid by Medicare$20,183
Procedure codes3

Dr. Tawagi's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 1902024: 16215%
Other services
2023: 02024: 102

Dr. Tawagi compared with the Illinois median for hematologists and oncologists, 2024

  • Dr. Tawagi
  • Illinois median
Medicare services
264vs 1,05675% below
Medicare patients
67vs 28276% below
Part D claims
527vs 32861% above

Medians across 547 hematologists and oncologists in Illinois with Dmand AI profiles that report each measure.

Dr. Tawagi's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Tawagi

Need commercial claims for Dr. Tawagi?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Tawagi and other hematologists and oncologists in Illinois.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Karine Tawagi treated 67 Medicare patients in 2024, average age 71

CMS counts 67 Medicare patients who saw Dr. Tawagi in 2024. The largest group is 65 to 74, with 38 patients. 75% of them have cancer, and 75% have high blood pressure. 64% are also on Medicaid. Their average risk score is 2.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tawagi's median patient age at 69, with 22% women.

Medicare patients, 202467
Average age71
Average risk score2.70
Also on Medicaid64%

Dr. Tawagi's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Chronic conditions among Dr. Tawagi's Medicare patients, 2024

  1. Cancer75%
  2. High blood pressure75%
  3. High cholesterol43%
  4. Chronic kidney disease40%
  5. Arthritis39%
  6. Diabetes34%
  7. Ischemic heart disease30%
  8. Anxiety25%

Share of Medicare patients with each condition. A patient can have several.

Dr. Tawagi's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 69

Patient panel by sex, all payers

  • Women22%
  • Men78%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Karine Tawagi wrote 690 Medicare Part D claims in 2024

In 2024, Dr. Tawagi wrote 690 Medicare Part D claims for 76 patients. 81% of them were for generic drugs. CMS names the drug for 527 of them, across 11 drugs with 11 or more claims each, at $1,134,236 in total drug cost. In 2023, CMS named 272 claims across 8 drugs.

Part D claims, 2024690
Drugs named by CMS11
Total drug cost$1.1M
Part D patients76

Dr. Tawagi's Part D claims by kind of drug, 2024

  • Generic556 claims81%
  • Brand-name134 claims19%

Dr. Tawagi's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Tawagi's Part D claims, 2024

  • Opioids8%57 of 690 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 2722024: 52794%

Drugs named by CMS: 11 in 2024, 8 in 2023.

See all prescribing by Dr. Tawagi

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Karine Tawagi scored 93 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Tawagi for performance year 2024, reported as part of a group. Dr. Tawagi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tawagi as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Tawagi's MIPS scores, performance year 2024

  • 93of 100Final score
  • 73.5of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 71of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Tawagi by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Karine Tawagi received $52,308 in industry payments from 2018 to 2025

CMS Open Payments shows 115 general payments to Dr. Tawagi from 26 drug and device companies from 2018 to 2025. Speaker and faculty fees make up the largest share, 60% of the total. AstraZeneca Pharmaceuticals LP paid the most, $39,670.

General payments to Dr. Tawagi by program year, 2018 to 2025

General payments to Dr. Tawagi by kind, 2018 to 2025

$52.3Kin total
  • Speaker and faculty fees$31,46060%
  • Consulting fees$9,97819%
  • Food and beverage$6,47712%
  • Honoraria$1,9924%
  • Other$2,4025%

Companies that paid Dr. Tawagi the most, 2018 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Tawagi

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. Karine Tawagi's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Karine Tawagi

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Karine Tawagi's NPI number?

Dr. Karine Tawagi's NPI number is 1447633235. It was assigned on June 30, 2015, and it is active in the NPI Registry.

What kind of doctor is Dr. Karine Tawagi?

Dr. Karine Tawagi is a hematologist and oncologist in Chicago, Illinois. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Karine Tawagi practice?

Dr. Tawagi practices at 1740 West Taylor St Suite 1400, Chicago, IL 60612. Dr. Tawagi's primary practice is University of Illinois Hospital in Chicago, Illinois, part of University of Illinois System. Dmand AI also links Dr. Tawagi to 1 group practice or clinic.

What is Dr. Karine Tawagi's office phone number?

The practice phone on file for Dr. Tawagi is (312) 996-3900.

What is Dr. Karine Tawagi's medical license number?

Dr. Tawagi holds Illinois license 036162147, one of the licenses on file in 2 states.

Which states has Dr. Karine Tawagi been licensed in?

Dmand AI has state licenses on file for Dr. Tawagi in Illinois and Michigan.

Which hospitals is Dr. Karine Tawagi affiliated with?

Dr. Tawagi practices at University of Illinois Hospital in Chicago, Illinois.

What medical group is Dr. Karine Tawagi part of?

Dr. Tawagi is linked to University of Illinois Physicians Group (UIPG).

Does Dr. Karine Tawagi accept Medicare?

Yes. CMS data shows Dr. Tawagi billed Medicare for 264 services in 2024, and Dr. Tawagi accepts Medicare assignment.

Does Dr. Karine Tawagi offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Tawagi as offering telehealth services.

Show 6 more questionsShow fewer questions

What is Dr. Karine Tawagi's MIPS score?

Dr. Tawagi's MIPS final score for performance year 2024 is 93 out of 100, reported as part of a group.

How many Medicare patients does Dr. Karine Tawagi see?

CMS counts 67 Medicare patients who saw Dr. Tawagi in 2024, with an average age of 71.

What services does Dr. Karine Tawagi bill to Medicare?

In 2024, Dr. Tawagi's most billed Medicare services were office visit, established patient (99215), medicare service (G2211) and office visit, new patient (99205).

What drugs does Dr. Karine Tawagi prescribe most?

In 2024 Medicare Part D data, Dr. Tawagi's most prescribed drugs by claims were Prednisone, Abiraterone Acetate and Nubeqa.

Has Dr. Karine Tawagi received payments from drug or device companies?

CMS Open Payments shows $52,308 in general payments to Dr. Tawagi from 26 companies from 2018 to 2025. The largest total came from AstraZeneca Pharmaceuticals LP.

How long has Dr. Karine Tawagi been practicing?

Dr. Tawagi graduated from medical school in 2015, 11 years ago.

Selling to hematology and oncology practices?

See hematologists and oncologists in Illinois by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)